TSXV · SGMD.V
Salona Global Medical Device Corporation
CA$0.22-CA$0.01 (-4.35%)
Salona Global Medical Device Corporation’s quoted price sits in the lower half of its reported 52-week range, 56.0% below the high.
Loading market information…
TSX · REUN.TO · CAD
Stock price, earnings
Quote as of Aug 2, 2023, 06:41 PM UTC. Cached market data; not a live quote.
One-year closing-price history · CAD. Historical prices are not a forecast.
Reunion Neuroscience Inc.’s quoted price sits in the lower half of its reported 52-week range, 84.96% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Reunion Neuroscience Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Field Trip Health Ltd. is a company based in Toronto, Canada, that specializes in developing and delivering psychedelic-assisted therapies across North America. The firm manages Field Trip Health Centres, which administer psychedelic treatments, and offers Field Trip Digital applications. Additionally, through its Field Trip Discovery division, it conducts research to create innovative psychedelic molecules. The company provides ketamine-assisted therapy for various conditions, including depression, anxiety, and addiction. Field Trip Health Ltd. was founded in 2008.
Latest available per-share figures in CAD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:46 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CA$0.22-CA$0.01 (-4.35%)
Salona Global Medical Device Corporation’s quoted price sits in the lower half of its reported 52-week range, 56.0% below the high.
CA$5.10-CA$3.40 (-40.0%)
IM Cannabis Corp.’s quoted price sits in the lower half of its reported 52-week range, 47.42% below the high.
CA$0.30+CA$0.04 (+13.46%)
Antibe Therapeutics Inc.’s quoted price sits in the lower half of its reported 52-week range, 76.02% below the high.
CA$0.20CA$0.00 (0.0%)
EXMceuticals Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
CA$0.11CA$0.00 (0.0%)
LexaGene Holdings Inc.’s quoted price sits in the lower half of its reported 52-week range, 65.0% below the high.
CA$0.10-CA$0.01 (-4.76%)
RIV Capital Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
CA$0.03CA$0.00 (0.0%)
Tetra Bio-Pharma Inc.’s quoted price sits in the lower half of its reported 52-week range, 66.67% below the high.
$0.02-$0.00 (-20.0%)
Numinus Wellness Inc.’s quoted price sits in the lower half of its reported 52-week range, 70.91% below the high.
